Vr Adviser, LLC Oric Pharmaceuticals, Inc. Transaction History
Vr Adviser, LLC
- $966 Million
- Q3 2024
A detailed history of Vr Adviser, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 4,394,527 shares of ORIC stock, worth $38.4 Million. This represents 4.67% of its overall portfolio holdings.
Number of Shares
4,394,527
Previous 4,394,527
-0.0%
Holding current value
$38.4 Million
Previous $31.1 Million
44.98%
% of portfolio
4.67%
Previous 3.41%
Shares
3 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$46.2 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$42.2 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$36.2 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$35 Million0.16% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$34.1 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $346M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...